MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/00042737-200503000-00014

Медицинская библиотека · European journal of gastroenterology & hepatology · 2005

Serum lipid profile and hepatic steatosis of adult beta-thalassaemia patients with chronic HCV infection.

Siagris Dimitrios, Kouraklis-Symeonidis Alexandra, Christofidou Myrto, Lekkou Alexandra, Papadimitriou Christos, Arvaniti Vassiliki, Thomopoulos Konstantinos, Tsamandas Athanasios, Zoumbos Nicholas, Labropoulou-Karatza Chryssoyla

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

The aim of this study was to evaluate the serum lipid profile and to assess the prevalence of hepatic steatosis in adult beta-thalassaemic patients with chronic hepatitis C virus (HCV) infection.

METHODS

Thirty-five adult HCV infected, multi-transfused, beta-thalassaemia patients (beta-HCV patients), 63 otherwise normal patients with chronic HCV infection (HCV patients) and 54 beta-thalassaemia patients without chronic viral hepatitis (beta patients) were studied. Total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides, viral markers and liver histology were evaluated.

RESULTS

Serum total cholesterol, HDL-C and LDL-C were found at significantly lower levels in beta-HCV and beta patients than in HCV patients. Triglyceride levels were significantly lower in the HCV group compared with the beta group. Nine (25.7%) of the 35 beta-HCV patients had mild hepatic steatosis. Thirteen (23.6%) of 55 HCV patients presented mild and 4/55 (7.3%) moderate hepatic steatosis. None of the beta group presented steatosis. When we compared beta-HCV and HCV patients with steatosis, we found that beta-HCV patients had a lower degree of steatosis (11.1+/-7% vs 22.9+/-17.2%, P=0.021). Multivariate logistic regression analysis showed that the only independent predictor associated with hepatic steatosis in beta-HCV and HCV patients was genotype 3a (OR, 3.61; 95% CI, 1.22-10.71, P=0.021).

CONCLUSIONS

Adult beta-thalassaemia patients, compared to other patients with chronic HCV infection, present lower cholesterol levels (total cholesterol, HDL, LDL) and similar frequency but a lower degree of hepatic steatosis. This difference in the degree of steatosis is most likely due to the higher prevalence of genotype 3a in the non-beta-thalassaemia group.

Для цитирования: Siagris Dimitrios, Kouraklis-Symeonidis Alexandra, Christofidou Myrto, Lekkou Alexandra, Papadimitriou Christos, Arvaniti Vassiliki, Thomopoulos Konstantinos, Tsamandas Athanasios, Zoumbos Nicholas, Labropoulou-Karatza Chryssoyla. Serum lipid profile and hepatic steatosis of adult beta-thalassaemia patients with chronic HCV infection.. European journal of gastroenterology & hepatology. 2005. DOI: 10.1097/00042737-200503000-00014.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.